
NSE: NGLFINE · Healthcare · Pharmaceuticals · Market cap ₹1,926 Cr
· Prev close ₹2,934.30 · Volume 10.70 K · 52W ₹1,271–3,602
Same session as: Analysts/Institutional Investor Meet/Con. Call Updates, filed 12 Nov 2026, 10:50 pm IST
Generated NGL Fine-Chem Limited said the audio recording of its Q2 & H1 FY27 earnings conference call, held on November 12, 2026 at 11:00 AM IST, has been uploaded to…
Shown when the day move is above 5%: the most material filing of this session and the one before.
Profit before interest and tax per ₹100 of capital employed.
Median of the other 5: 15.9%
Net profit per ₹100 of shareholders' equity.
Median of the other 3: 16.5%
Last 4 quarters 19.3%